| 產品名稱 | CDIBA |
| 產品貨號 | Axon 1609 CAS [479422-22-5] MF C31H26ClNO3MW 496.00 Purity: 100% Soluble in DMSO Description Potent and selective cytosolic phospholipase A2 (cPLA2) inhibitor References Certificates Categories Extra info Novel Target for Existing Drug May Improve Success of Radiation Therapy. ScienceDaily Sep. 20, 2010.? ? AG Linkous et al. Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis. J. Natl. Cancer Inst. 2010; 102(18), 1398-1412.? Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Diabetes & Metabolism Pain & Inflammation EC 3.1.1.4 PLA2 cPLA2 inhibitor Chemical name 4-[2-[5-chloro-1-(diphenylmethyl)-2-methyl-1H-indol-3-yl]-ethoxy]benzoic acid Parent CAS No. [479422-22-5] Order Size Unit Price Stock 5 mg €125.00 In Stock |
| 產品價格 | 現貨詢價，電話：010-67529703 |
| 產品規格 | |
| 產品品牌 | axonmedchem |
| 產品概述 | |
| 產品詳情 |
CDIBAAxon 1609 CAS [479422-22-5] MF C31H26ClNO3
Description
Potent and selective cytosolic phospholipase A2 (cPLA2) inhibitor
cPLA2 inhibitor
Chemical name4-[2-[5-chloro-1-(diphenylmethyl)-2-methyl-1H-indol-3-yl]-ethoxy]benzoic acid Parent CAS No.[479422-22-5] |
| 產品資料 |
